Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Nov 14, 2019BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Jefferies 2019 London Healthcare Conference on Thursday,...
Nov 12, 2019BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug...
-
Nov 5, 2019- As reported, full fiscal year revenues of $17.290 billion increased 8.2 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.584 billion for the fourth fiscal quarter ended September 30,...
-
Oct 29, 2019
FRANKLIN LAKES, N.J., and WAGENINGEN, THE NETHERLANDS, October 29, 2019 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, along with Check-Points...
-
Oct 28, 2019BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit is designed and tested to work with BD Rhapsody™ Single-Cell Analysis System, BD® AbSeq reagents and BD® Single-Cell Multiplexing Kit
Franklin Lakes, N.J., October 28, 2019 – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the availability of BD Rhapsody WTA Amplification kit...
-
Oct 3, 2019
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2019 earnings conference call on Tuesday,...
-
Sep 28, 2019Independent analysis of LUTONIX® 035 Drug Coated Balloon patient-level data showed no statistically significant mortality increase
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the publication of a company-initiated, independent analysis of the LUTONIX® 035 Drug...
Sep 26, 2019Thomas E. Polen Appointed Chief Executive Officer, Effective Jan. 28, 2020BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Vincent A. Forlenza, chairman and CEO, will retire as CEO on Jan. 28, 2020,...
Aug 21, 2019BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: Wells...
Aug 6, 2019- As reported, revenues of $4.350 billion increased 1.7 percent.BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.350 billion for the third fiscal quarter ended June 30, 2019....
-
Jul 23, 2019
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2018 Sustainability Report, focusing on management of the environmental, social and...
-
Jul 22, 2019
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 per common share, payable on September 30, 2019 to holders of record on...
-
Jul 18, 2019
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls related to certain Alaris™ Pump Modules Model 8100...
-
Jul 2, 2019
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2019 earnings conference call on Tuesday, August 6, 2019, at 8:00 a.m....
-
Jun 20, 2019
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement following the U.S. Food and Drug Administration (FDA) Circulatory...
-
Jun 4, 2019
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the consideration payable in connection with its previously announced tender offers to purchase for cash, in the...
-
Jun 4, 2019Findings Based on Survey of 650 Health Care Professionals
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released a new report based on an independent national survey that examines drug diversion in...
-
Jun 3, 2019
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the early tender results for its previously announced tender offers to purchase for cash, in the order of priority...
-
May 31, 2019
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Goldman Sachs 40th Annual Global Healthcare Conference on...
-
May 20, 2019
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced that it has commenced tender offers to purchase for cash the debt securities issued by the Company listed in the...
-
May 9, 2019- As reported, revenues of $4.195 billion decreased 0.6 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.195 billion for the second fiscal quarter ended March 31, 2019....
Apr 30, 2019New BD ChloraPrep™ Skin Preparation is the Only Commercially Available CHG Antiseptic Skin Preparation with Sterile Solution Designation in the U.S.BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for BD ChloraPrep™...
Apr 8, 2019BD BACTEC™ Platelet Quality Control Media is cleared by the U.S. Food and Drug Administration and CE-IVD marked for platelet testingBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global availability of BD BACTEC™ platelet quality control media, which allows...
Mar 26, 2019BD FACSDuet(TM) system raises the bar on flow cytometry automation offering a fully integrated sample-to-answer solution with the BD FACSLyric(TM) clinical flow cytometerBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE-IVD certification for the BD FACSDuet(TM) automated flow cytometry system. The...
-
Mar 21, 2019
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement related to the recent letter from FDA to health care providers...
Mar 14, 2019Venovo(TM) Venous Stent proven safe and effective in iliac and femoral veinsBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo(TM)...
-
Feb 13, 2019BD WavelinQ™ 4F EndoAVF System Receives 510(k) Clearance from U.S. Food and Drug Administration
FRANKLIN LAKES, N.J., February 13, 2019 –BD (Becton, Dickinson and Company), a leading global medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration for...
-
Feb 5, 2019- As reported, revenues of $4.160 billion increased 35.1 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.160 billion for the first fiscal quarter ended December 31,...
-
Jan 24, 2019BD Nano(TM) Second Generation Pen Needle Receives 510(k) Clearance from U.S. Food and Drug Administration
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the U.S. Food and Drug Administration 510(k) clearance of its second generation BD Nano(TM)...
-
Dec 20, 2018BD MAX(TM) Enteric Viral Panel Receives 510(k) Clearance from U.S. Food and Drug Administration
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration 510(k) clearance of its BD MAX(TM) enteric viral...
Dec 11, 2018BD FACSLyric(TM) Flow Cytometer is First BD Product to Earn UL Cybersecurity Assurance Program CertificationBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of an enterprise level cybersecurity assessment from UL. This...
-
Nov 29, 2018Learn how advanced analytics can help combat a critical component of the opioid epidemic at the #ASHP18 Midyear Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new software application designed to help hospitals and health systems...
-
Nov 13, 2018Fully-automated BD Phoenix(TM) CPO Detect Test Receives U.S. FDA Clearance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration 510(k) clearance of the BD Phoenix(TM) CPO detect...
-
Nov 6, 2018- As reported, full fiscal year revenues of $15.983 billion increased 32.2 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.402 billion for the fourth fiscal quarter ended September 30,...
-
Oct 29, 2018
BD MedMined™ Surveillance Advisor has earned Meaningful Use Stage 3 (MU3) certification validating its ability to collect and properly report data around antimicrobial use and resistance data by...
-
Oct 23, 2018Brings Total Company Investment in Nebraska to $340 Million in Two Years
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to announce a $200 million...
Oct 17, 2018Company Joins Effort Alongside Rotary and Leading Global Health Organizations to Expand Vaccinations in IndiaBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a donation of 20 million syringes valued at $1 million to Rotary, a nonprofit...
-
Oct 16, 2018BD MAX(TM) MDR-TB Panel Obtains CE-IVD Status in Europe
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of the BD MAX(TM) MDR-TB panel in Europe. Clinicians can use the test...
-
Aug 28, 2018
BD (Becton, Dickinson and Company), Direct Relief, and the National Association of Community Health Centers (NACHC) recently awarded five community health centers with a total of $1 million in...
-
Aug 2, 2018
Click on the links below to view results for the 2018 third fiscal quarter: View document online PDF file of BD 2018 third fiscal quarter results About BD BD is one of the largest global medical...
Jul 26, 2018BD® AbSeq Assay Enables Deeper Understanding of Role Individual Cells Play in the Immune SystemBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD(®) AbSeq assay to analyze protein expression at the...
-
Jul 12, 2018
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that...
-
Jul 9, 2018everlinQ(TM) endoAVF System Receives FDA De Novo Marketing Authorization
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of TVA Medical, Inc., a company that develops...
-
Jun 27, 2018
Alexandria, VA., June 27, 2018 – In an effort to improve evidence-based care in Free and Charitable Clinics using point-of-care testing results, BD (Becton, Dickinson and Company) (NYSE: BDX) in...
-
Jun 18, 2018Visit BD Booth #9 and 10 to Learn how the Most Common Invasive Procedure doesn’t Need to be One of the Most Complex
Copenhagen, June 20, 2018 - During the 5th annual World Congress on Vascular Access (WoCoVA) being held June 20-22 in Copenhagen, BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global...
-
Jun 4, 2018BD Pyxis(TM) ES Refrigerator Expands Enterprise-wide Medication Management Solutions from BD to Improve Refrigerated Medication Management and Security
BD, Helmer Scientific Collaborate to Introduce First Fully Integrated Refrigerated Automated Dispensing Solution BD Pyxis(TM) ES Refrigerator Expands Enterprise-wide Medication Management...
-
May 3, 2018
Click on the links below to view results for the 2018 second fiscal quarter: View document online PDF file of BD 2018 second fiscal quarter results About BD BD is one of the largest global medical...
-
Apr 27, 2018Alberto Mas to Lead Medical Segment;
BD Names Three Executives to Segment Leadership Roles Alberto Mas to Lead Medical Segment; Patrick Kaltenbach to Lead Life Sciences Segment; Bill Tozzi to Lead Interventional Segment on Interim Basis
Apr 26, 2018New Cell Sorter Extends BD's Robust Portfolio of Flow Cytometry Research SolutionsBD Launches BD FACSymphony(TM) S6 High Parameter Cell Sorter to Enable Sorting of Rare Cell Types New Cell Sorter Extends BD's Robust Portfolio of Flow Cytometry Research Solutions FRANKLIN LAKES,...
Apr 19, 2018BD Synapsys(TM) Microbiology Informatics Solution Among New Offerings Shown at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)BD Unveils Suite of Diagnostic Informatics and Automation Innovations BD Synapsys(TM) Microbiology Informatics Solution Among New Offerings Shown at European Congress of Clinical Microbiology and...